Zuranolone FDA approval – Sage Therapeutics SAGE and Biogen BIIB

What does the next week and the next few years have in store for these 2 companies’ stocks after zuranolone FDA approval?

The Food and Drug Administration announced Friday it has approved the first oral treatment for postpartum depression. The drug, called zuranolone, is a once-a-day pill that will be branded as Zurzuvae by drugmakers Sage Therapeutics and Biogen.

I am long SAGE.

https://www.cbsnews.com/news/fda-approves-zuranolone-first-pill-for-postpartum-depression/